Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Charles Nicholas Serhan, Ph.D.

Co-Author

This page shows the publications co-authored by Charles Serhan and Dipak Panigrahy.
Connection Strength

1.827
  1. COVID-19 and cancer: start the resolution! Cancer Metastasis Rev. 2022 03; 41(1):1-15.
    View in: PubMed
    Score: 0.247
  2. Resolution of inflammation: An organizing principle in biology and medicine. Pharmacol Ther. 2021 11; 227:107879.
    View in: PubMed
    Score: 0.233
  3. Carcinogenesis: Failure of resolution of inflammation? Pharmacol Ther. 2021 02; 218:107670.
    View in: PubMed
    Score: 0.223
  4. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? Cancer Metastasis Rev. 2020 06; 39(2):337-340.
    View in: PubMed
    Score: 0.219
  5. Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases. J Clin Invest. 2019 06 17; 129(7):2964-2979.
    View in: PubMed
    Score: 0.205
  6. Aspirin-triggered proresolving mediators stimulate resolution in cancer. Proc Natl Acad Sci U S A. 2019 03 26; 116(13):6292-6297.
    View in: PubMed
    Score: 0.201
  7. Targeting lipid mediators in cancer biology. Cancer Metastasis Rev. 2018 09; 37(2-3):557-572.
    View in: PubMed
    Score: 0.194
  8. Resolvins suppress tumor growth and enhance cancer therapy. J Exp Med. 2018 01 02; 215(1):115-140.
    View in: PubMed
    Score: 0.184
  9. Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat. 2011 Nov; 96(1-4):27-36.
    View in: PubMed
    Score: 0.119
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.